Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis

Clinical trial NCT00524836 · COMPLETED

Trial details

NCT number: NCT00524836
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rhinitis Allergic Perennial

Start date: 2003-09-01
Primary completion: 2004-02-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.